Allovir Stock Total Asset
| ALVR Stock | USD 0.55 0.02 3.51% |
Allovir fundamentals help investors to digest information that contributes to Allovir's financial success or failures. It also enables traders to predict the movement of Allovir Stock. The fundamental analysis module provides a way to measure Allovir's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Allovir stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 190.8 M | 236.5 M |
Allovir | Total Asset |
Allovir Company Total Asset Analysis
Allovir's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Allovir Total Asset | 190.8 M |
Most of Allovir's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Allovir is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Allovir Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Allovir is extremely important. It helps to project a fair market value of Allovir Stock properly, considering its historical fundamentals such as Total Asset. Since Allovir's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Allovir's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Allovir's interrelated accounts and indicators.
Click cells to compare fundamentals
Allovir Total Asset Historical Pattern
Today, most investors in Allovir Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Allovir's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Allovir total asset as a starting point in their analysis.
Allovir Total Asset |
| Timeline |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Allovir Total Assets
Total Assets |
|
Based on the latest financial disclosure, Allovir has a Total Asset of 190.8 M. This is 97.46% lower than that of the Biotechnology sector and 90.34% lower than that of the Health Care industry. The total asset for all United States stocks is 99.35% higher than that of the company.
Allovir Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Allovir's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Allovir could also be used in its relative valuation, which is a method of valuing Allovir by comparing valuation metrics of similar companies.Allovir is currently under evaluation in total asset category among its peers.
Allovir Current Valuation Drivers
We derive many important indicators used in calculating different scores of Allovir from analyzing Allovir's financial statements. These drivers represent accounts that assess Allovir's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Allovir's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.7B | 1.0B | 812.4M | 393.2M | 70.7M | 67.2M | |
| Enterprise Value | 1.6B | 920.0M | 640.8M | 322.5M | 8.0M | 7.6M |
Allovir Institutional Holders
Institutional Holdings refers to the ownership stake in Allovir that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Allovir's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Allovir's value.| Shares | Geode Capital Management, Llc | 2024-09-30 | 585.5 K | Rbf Llc | 2024-06-30 | 449 K | Marshall Wace Asset Management Ltd | 2024-06-30 | 324.7 K | Fmr Inc | 2024-09-30 | 310.6 K | D. E. Shaw & Co Lp | 2024-09-30 | 296.5 K | Two Sigma Investments Llc | 2024-09-30 | 295.2 K | Goldman Sachs Group Inc | 2024-06-30 | 288 K | State Street Corp | 2024-06-30 | 222.4 K | Commonwealth Equity Services Inc | 2024-06-30 | 201 K | Ecor1 Capital, Llc | 2024-09-30 | 11.3 M | Octagon Capital Advisors Lp | 2024-09-30 | 11.2 M |
Allovir Fundamentals
| Return On Equity | -0.8 | ||||
| Return On Asset | -0.37 | ||||
| Current Valuation | (58.32 M) | ||||
| Shares Outstanding | 115.36 M | ||||
| Shares Owned By Insiders | 49.11 % | ||||
| Shares Owned By Institutions | 42.94 % | ||||
| Number Of Shares Shorted | 3.95 M | ||||
| Price To Book | 0.52 X | ||||
| Gross Profit | 165 K | ||||
| EBITDA | (190.15 M) | ||||
| Net Income | (190.42 M) | ||||
| Cash And Equivalents | 172.67 M | ||||
| Cash Per Share | 1.91 X | ||||
| Total Debt | 27.43 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 8.18 X | ||||
| Book Value Per Share | 1.05 X | ||||
| Cash Flow From Operations | (124.45 M) | ||||
| Short Ratio | 26.44 X | ||||
| Earnings Per Share | (0.90) X | ||||
| Price To Earnings To Growth | (0.06) X | ||||
| Target Price | 1.2 | ||||
| Beta | 0.74 | ||||
| Market Capitalization | 85.25 M | ||||
| Total Asset | 190.8 M | ||||
| Retained Earnings | (656.19 M) | ||||
| Working Capital | 159.27 M | ||||
| Current Asset | 61.62 M | ||||
| Current Liabilities | 53.23 M | ||||
| Net Asset | 190.8 M |
About Allovir Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Allovir's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allovir using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allovir based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Allovir
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allovir position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will appreciate offsetting losses from the drop in the long position's value.Moving against Allovir Stock
The ability to find closely correlated positions to Allovir could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allovir when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allovir - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allovir to buy it.
The correlation of Allovir is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allovir moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allovir moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allovir can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Allovir Stock Analysis
When running Allovir's price analysis, check to measure Allovir's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allovir is operating at the current time. Most of Allovir's value examination focuses on studying past and present price action to predict the probability of Allovir's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allovir's price. Additionally, you may evaluate how the addition of Allovir to your portfolios can decrease your overall portfolio volatility.